Cambridge, MA – According to filings with the U.S. Securities and Exchange Commission, Celsius Therapeutics is raising $65,000,000.00 in a new round of investment. Sources indicate as part of senior management Chief Executive Officer, Tariq Kassum played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About Celsius Therapeutics

Celsius Therapeutics is a community of scientists, technologists, clinicians and drug hunters leveraging single-cell RNA sequencing and genomic analysis to develop life-changing medicines. Our common goal is to markedly improve human health by integrating data, experience and insight. Located in Cambridge, Mass., our environment is rigorous, fast-paced and collaborative, bringing together passionate individuals who are making an impact. We inspire creativity and discovery by embracing an open culture that fosters innovation, teamwork and excellence.

To learn more about Celsius Therapeutics, visit http://celsiustx.com/

Contact:
Tariq Kassum, Chief Executive Officer
857-776-7400
https://www.linkedin.com/in/christoph-lengauer-75b7961b/

SOURCE: http://www.intelligence360.io
Copyright (c) 2019 SI360 Inc. All rights reserved